Related references
Note: Only part of the references are listed.Screening for Hepatitis B Virus Infection in Pregnancy: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
ANNALS OF INTERNAL MEDICINE (2013)
Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy
Sung-Nan Pei et al.
ANNALS OF HEMATOLOGY (2012)
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection
D. H. T. Mya et al.
ANNALS OF ONCOLOGY (2012)
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine
Angela Rago et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis
Urszula Zurawska et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation
Chin Y Liu et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2012)
Review article: current antiviral therapy of chronic hepatitis B
W. S. Ayoub et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis
Yu Xuan Koo et al.
ANNALS OF HEMATOLOGY (2011)
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
A. M. Evens et al.
ANNALS OF ONCOLOGY (2011)
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy
J. Yun et al.
BRITISH JOURNAL OF CANCER (2011)
Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load
Melanie Deutsch et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation
Ramazan Idilman et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Cost-Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Solid Tumors
Fiona L. Day et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy
Yeo Myeong Kim et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection
Tatyana A. Shamliyan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2011)
Reactivation of Overt and Occult Hepatitis B Infection in Various Immunosuppressive Settings
Nicola Coppola et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Non-Hodgkin's Lymphomas
Andrew D. Zelenetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
Bhumsuk Keam et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy
H. -R. Li et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Reactivation of hepatitis B virus following bendamustine-containing chemotherapy in a patient with multiple myeloma
Umit Tapan et al.
LEUKEMIA & LYMPHOMA (2011)
Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy
Jorge Mendez-Navarro et al.
LIVER INTERNATIONAL (2011)
An Argument for the Universal Prophylaxis of Hepatitis B Infection in Patients Receiving Rituximab: A 7-Year Institutional Experience of Hepatitis Screening
Christopher Leung et al.
ONCOLOGIST (2011)
Occult hepatitis B virus infection: A complex entity with relevant clinical implications
Juan Ramon Larrubia
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Diagnostic strategy for occult hepatitis B virus infection
Sara Ocana et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
The role of anti-core antibody response in the detection of occult hepatitis B virus infection
Simona Urbani et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/HBcAb-positive: a multicenter retrospective study
Dongmei Ji et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin's lymphoma in an HBV carrier
Tomoki Aomatsu et al.
EUROPEAN JOURNAL OF PEDIATRICS (2010)
Managing HBV in patients with impaired immunity
Karsten Wursthorn et al.
GUT (2010)
Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies
Muenci Yagci et al.
HEMATOLOGY (2010)
Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma
Michihiro Uchiyama et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
Karl-Dimiter Bissig et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases
Andrew S. Artz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination Chemotherapy
Nozomi Niitsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy
Wing-I. Cheung et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer
P. Borentain et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Hepatitis B Reactivation and Rituximab in the Oncology Practice
Jeryl Villadolid et al.
ONCOLOGIST (2010)
Fatal Reactivation of Occult Hepatitis B Virus Infection after Rituximab and Chemotherapy in Lymphoma: Necessity of Antiviral Prophylaxis
Beibei Zhang et al.
ONKOLOGIE (2010)
Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia
Donald M. Arnold et al.
TRANSFUSION (2010)
Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
Sylvia Brost et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier
N. Fukushima et al.
ANNALS OF ONCOLOGY (2009)
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Tara N. Palmore et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance
Panayiotis D. Ziakas et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Prevention of hepatitis B virus reactivation under rituximab therapy
Yutaka Tsutsumi et al.
IMMUNOTHERAPY (2009)
SYNERGISTIC EFFECT OF RADIATION AND INTERLEUKIN-6 ON HEPATITIS B VIRUS REACTIVATION IN LIVER THROUGH STAT3 SIGNALING PATHWAY
Chia Hung Chou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Fatal Reactivation of Hepatitis B Virus in a Patient Who Was Hepatitis B Surface Antigen Negative and Core Antibody Positive Before Receiving Chemotherapy for Non-Hodgkin Lymphoma
Jia-Min Wu et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers
Marcel Miedouge et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia
Davide Rossi et al.
LEUKEMIA & LYMPHOMA (2009)
Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
Donatella Ferraro et al.
LIVER INTERNATIONAL (2009)
Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience
Orhan Onder Eren et al.
MEDICAL ONCOLOGY (2009)
Anti-HBc alone in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients
Yu Xuan Koo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Systematic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy
Rohit Loomba et al.
ANNALS OF INTERNAL MEDICINE (2008)
Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma
Philippe Colson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B
Hie-Won Hann et al.
HEPATOLOGY INTERNATIONAL (2008)
Hepatitis B reactivation after chemotherapy: two decades of clinical research
George K. K. Lau
HEPATOLOGY INTERNATIONAL (2008)
Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen
D. Huzly et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Erratum to ‘The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting’ [J. Clin. Virol. 41 (4) 2008 243–254]
Stephen Barclay et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
Robert G. Gish et al.
GASTROENTEROLOGY (2007)
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model
Sammy Saab et al.
HEPATOLOGY (2007)
Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California
Steven Y. Lin et al.
HEPATOLOGY (2007)
Fatal reactivation of hepatitis B with temozolomide
Jai Grewal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient
Sabine Awerkiew et al.
JOURNAL OF CLINICAL VIROLOGY (2007)
Hepatitis B virus reactivation induced by Yttrium-90-ibritumomab-tiuxetan
Timucin Cil et al.
LEUKEMIA & LYMPHOMA (2007)
Occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2007)
Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection
H. E. Kohrt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations
A. Alexopoulou et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine
Alexandra Alexopoulou et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
Chee-Kin Hui et al.
GASTROENTEROLOGY (2006)
False-positive hepatitis serology after administration of immunoglobulins
E. Strobel et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2006)
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H
Agostino Cortelezzi et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
W Yeo et al.
HEPATOLOGY (2006)
Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment
K Ikeda et al.
LEUKEMIA & LYMPHOMA (2006)
Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests
M. Schmidt et al.
VOX SANGUINIS (2006)
Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab
Toshiki Sera et al.
INTERNAL MEDICINE (2006)
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations
JK Law et al.
LEUKEMIA & LYMPHOMA (2005)
Hepatitis B virus reactivation and alemtuzumab therapy
E Iannitto et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy
S Zhong et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: A prospective study
W Yeo et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
AL Cheng et al.
HEPATOLOGY (2003)
Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation
PM Chen et al.
TRANSPLANTATION (2002)
Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.
I Dervite et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy
W Yeo et al.
JOURNAL OF VIRAL HEPATITIS (2000)
Share Paper
